In the latter half of 2026, beneath the usual noise of Big Tech, a wave of niche U.S. equities and thematic ETFs is quietly making waves. I'm told that following a string of successful billion-dollar IPOs this summer, Wall Street is taking a fresh look at these off-the-radar assets. Meanwhile, leveraged exchange-traded funds tied to single stocks are flooding the market at a rapid clip—perhaps the most significant overhaul of retail trading tools we've seen lately.

Bending Spoons (BSP.US)

The tech company's recent expansion has been aggressive. The stock has seen a noticeable pullback recently, but the underlying business is humming. According to people familiar with the matter, after raising over a billion dollars in its July 2026 Nasdaq IPO, Bending Spoons went on a buying spree, snagging Airtable and moving to acquire Miro. Q2 2026 revenue skyrocketed, and insiders suggest the company is targeting nearly 2.8 billion dollars in full-year revenue as it solidifies its grip on the collaboration software market.

Csquare (CSQR.US)

The data center operator also pulled off a massive July 2026 IPO. Though shares have faced some downward pressure over the past month, Wall Street remains firmly on board. Csquare reported record Q2 2026 revenue with strong double-digit growth year-over-year. I understand from multiple sources that prominent analysts are maintaining their "Buy" ratings, betting on the long-term value of its 62 interconnection sites across major metropolitan markets.

Fortrea Holdings (FTRE.US)

The global contract research organization has been busy reorganizing. The stock has experienced a bumpy ride over the past year. In September 2026, Fortrea announced a definitive agreement to acquire early phase clinical assets from Worldwide Clinical Trials. Adding to the intrigue, they recently reinstated their CFO after a legal dispute. This signals a concerted effort to stabilize operations, backed by a solid Q2 revenue base of over 600 million dollars.

Semnur Pharmaceuticals (SMNR.US)

This microcap biopharma name has seen some dramatic corporate maneuvers. I'm told the company signed a binding term sheet in July 2026 for a massive 100 million-dollar strategic investment from iHolding Group. The market is closely watching its non-opioid pain management product, SP-102, though the stock remains highly volatile at depressed levels as traders await commercialization updates.

Also

• Reitar Logtech Holdings (RITRF.US): The logistics firm announced a fresh share repurchase program in August 2026 and secured a multi-million dollar service arrangement, sparking recent trading interest.
• Allied Gaming & Entertainment (AIFA.US): Shares have slipped recently as the market awaits its next crucial earnings release scheduled for November 2026 to see if it can reverse its net losses.
• TDAQ Lift ETF (TDAX.US): The actively managed fund has been aggressive with its yield, declaring multiple dividends in September 2026 alone.
• Leveraged ETF Boom: There is a growing flood of single-stock derivatives. The T-REX 2X Long EOSE Daily Target ETF (EOSU.US), the Tradr 2X Short COHR Daily ETF (COHQ.US), and the Corgi COHR 2x Daily ETF (COHC.US) have all seen active trading recently. These tools are built purely for short-term speculation rather than long-term holds.

This article does not constitute investment advice.